01 1Chongqing Huapont Pharmaceutical Co Limited
02 1HAS Healthcare Advanced Synthesis SA
03 1HETERO DRUGS LIMITED
04 1Olon S.p.A.
05 1Olon SpA
06 1Siegfried PharmaChemikalien Minden GmbH
07 1Sionc Pharmaceutical Private Limited
01 1ISOTRETINOIN
02 4Isotretinoin
03 1Isotretinoin M
04 1Isotretinoin Micronized
01 1China
02 2India
03 2Italy
04 2Switzerland
NDC Package Code : 48943-0010
Start Marketing Date : 2003-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67262-0003
Start Marketing Date : 2012-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0135
Start Marketing Date : 1982-05-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0024
Start Marketing Date : 2012-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0083
Start Marketing Date : 2017-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65724-0051
Start Marketing Date : 2010-06-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0010
Start Marketing Date : 2019-12-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
36
PharmaCompass offers a list of Isotretinoin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Isotretinoin manufacturer or Isotretinoin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isotretinoin manufacturer or Isotretinoin supplier.
PharmaCompass also assists you with knowing the Isotretinoin API Price utilized in the formulation of products. Isotretinoin API Price is not always fixed or binding as the Isotretinoin Price is obtained through a variety of data sources. The Isotretinoin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Isosuprea Lidose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isosuprea Lidose, including repackagers and relabelers. The FDA regulates Isosuprea Lidose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isosuprea Lidose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Isosuprea Lidose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Isosuprea Lidose supplier is an individual or a company that provides Isosuprea Lidose active pharmaceutical ingredient (API) or Isosuprea Lidose finished formulations upon request. The Isosuprea Lidose suppliers may include Isosuprea Lidose API manufacturers, exporters, distributors and traders.
click here to find a list of Isosuprea Lidose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Isosuprea Lidose as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Isosuprea Lidose API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Isosuprea Lidose as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Isosuprea Lidose and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Isosuprea Lidose NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Isosuprea Lidose suppliers with NDC on PharmaCompass.
We have 6 companies offering Isosuprea Lidose
Get in contact with the supplier of your choice:
